Carregant...
Development of Modified Vaccinia Ankara-5T4 as Specific Immunotherapy for Advanced Human Cancer
BACKGROUND: The tumor-associated antigen 5T4 is expressed on a high percentage of human carcinomas and has limited expression in normal tissues. A recombinant pox virus vector expressing this antigen, modified vaccinia Ankara (MVA)-5T4, has been tested as a cancer vaccine. OBJECTIVE: Treatment with...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2008
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2592504/ https://ncbi.nlm.nih.gov/pubmed/18990081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712590802567298 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|